Franceschinis, E.; Roverso, M.; Gabbia, D.; De Martin, S.; Brusegan, M.; Vaccarin, C.; Bogialli, S.; Chilin, A.
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis. Pharmaceutics 2022, 14, 1806.
https://doi.org/10.3390/pharmaceutics14091806
AMA Style
Franceschinis E, Roverso M, Gabbia D, De Martin S, Brusegan M, Vaccarin C, Bogialli S, Chilin A.
Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis. Pharmaceutics. 2022; 14(9):1806.
https://doi.org/10.3390/pharmaceutics14091806
Chicago/Turabian Style
Franceschinis, Erica, Marco Roverso, Daniela Gabbia, Sara De Martin, Matteo Brusegan, Christian Vaccarin, Sara Bogialli, and Adriana Chilin.
2022. "Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis" Pharmaceutics 14, no. 9: 1806.
https://doi.org/10.3390/pharmaceutics14091806
APA Style
Franceschinis, E., Roverso, M., Gabbia, D., De Martin, S., Brusegan, M., Vaccarin, C., Bogialli, S., & Chilin, A.
(2022). Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4′-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis. Pharmaceutics, 14(9), 1806.
https://doi.org/10.3390/pharmaceutics14091806